RESUMO
Regulation of the cytosolic free Ca2+ concentration by nerve growth factor was investigated in C6-2B glioma cells newly expressing the high affinity nerve growth factor receptor trkA, using Fura-2 fluorescence ratio imaging. In these cells, nerve growth factor (50 ng/ml) evoked a novel approximately 3-fold increase in cytosolic free Ca2+ concentration, while no measurable Ca2+ response was observed in wild type or mock-transfected cells lacking a functional trkA receptor. K-252a, a tyrosine kinase inhibitor which prevents nerve growth factor-mediated responses in C6-2B cells expressing trkA, also blocked the rise in cytosolic free Ca2+ concentration by nerve growth factor. Moreover, basic fibroblast growth factor, which in these cells elicits biochemical changes similar to nerve growth factor, failed to affect cytosolic free Ca2+ concentration, further supporting the specificity of nerve growth factor/trkA receptor in mediating a Ca2+ response. While insensitive to chelation of extracellular Ca2+, the response was abolished following depletion of Ca2+ stores or blockade of intracellular Ca2+ release, providing strong evidence that intracellular Ca2+ is the main source for nerve growth factor-evoked cytosolic free Ca2+ concentration increase. Nerve growth factor increased the cytosolic free Ca2+ concentration also in NIH3T3 cells overexpressing trkA but devoid of p75 nerve growth factor receptor. Our data suggest that trkA but not p75 is required for nerve growth factor-evoked Ca2+ signaling.
Assuntos
Cálcio/metabolismo , Fatores de Crescimento Neural/farmacologia , Proteínas Proto-Oncogênicas/metabolismo , Receptores Proteína Tirosina Quinases/metabolismo , Receptores de Fator de Crescimento Neural/metabolismo , Células 3T3 , Animais , Carbazóis/farmacologia , Linhagem Celular , Citosol , Inibidores Enzimáticos/farmacologia , Fator 2 de Crescimento de Fibroblastos/farmacologia , Humanos , Alcaloides Indólicos , Líquido Intracelular/efeitos dos fármacos , Líquido Intracelular/metabolismo , Camundongos , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Inibidores de Proteínas Quinases , Proteínas Proto-Oncogênicas/genética , Ratos , Receptores Proteína Tirosina Quinases/genética , Receptor trkA , Receptores de Fator de Crescimento Neural/genética , Transdução de Sinais , TransfecçãoRESUMO
Treatment of both male and female rats with 5 IU/day mepartricin for 7-10 days administered by gastric tubing resulted in an increased faecal excretion of some steroids. Mean rate of elimination of total oestrogens was enhanced by 45% in male rats and by 14% in female rats, and the average excretion of conjugated oestrogen was also increased in the female animals. Faecal elimination of cholesterol was 37% and 42% higher in male and female rats, respectively, after mepartricin treatment, and in male rats plasma concentrations of cholesterol were reduced following treatment. It is suggested mepartricin acts either by changing the intestinal flora or by acting directly on the steroid moieties, and it is speculated that a similar mechanism may occur in man.
Assuntos
Estrogênios/metabolismo , Fezes/química , Mepartricina/farmacocinética , Testosterona/metabolismo , Administração Oral , Animais , Colesterol/metabolismo , Feminino , Intubação Gastrointestinal , Masculino , Mepartricina/administração & dosagem , Ratos , Ratos EndogâmicosRESUMO
Northern blot hybridization analysis was used to study regulation of nerve growth factor receptor (NGFR) mRNA content by glucocorticoids. Treatment for 6 h with dexamethasone (1 microM) caused a 40% decrease of NGFR mRNA content in PC12 cells and a 60% decrease in C6-2B glioma cells which was time and dose dependent. Dexamethasone (1 microM/kg) administered s.c. for two days to 21-day-old rats, elicits a 60% decrease in NGFR mRNA content in septum. These results suggest that the expression of NGFR gene in the brain could be inhibited by endogenous glucocorticoids. Whether dexamethasone inhibits NGFR gene expression by directly affecting cis-regulatory elements in the promoter regions of the gene remains to be elucidated.
Assuntos
Encéfalo/metabolismo , Dexametasona/farmacologia , Fatores de Crescimento Neural/metabolismo , RNA Mensageiro/genética , Receptores de Superfície Celular/genética , Neoplasias das Glândulas Suprarrenais , Animais , Encéfalo/efeitos dos fármacos , Linhagem Celular , Relação Dose-Resposta a Droga , Glioma , Cinética , Feocromocitoma , RNA Mensageiro/efeitos dos fármacos , Ratos , Receptores de Fator de Crescimento NeuralRESUMO
Mepartricin was given to cirrhotic patients in order to evaluate its effect on the imbalance of sex steroids which is typical of this disorder. Patients were divided into two group: one group received placebo (n = 19) and the other received 150,000 IU/day mepartricin for 30 days (n = 19). The patients were evaluated by separate medical staff who were unaware of the treatment. Mepartricin significantly decreased the plasma concentration of testosterone, oestradiol and prolactin as compared with the values at the start of the trial, while no significant changes were seen in the occurrence of gynaecomastia. No relevant changes were seen in patients receiving the control, except for a slight increase in the peripheral concentration of androstenedione, aldosterone and follicle stimulating hormone.
Assuntos
Androgênios/sangue , Estrogênios/sangue , Cirrose Hepática/tratamento farmacológico , Mepartricina/uso terapêutico , Polienos/uso terapêutico , Aldosterona/sangue , Ensaios Clínicos como Assunto , Hormônio Foliculoestimulante/sangue , Ginecomastia/sangue , Ginecomastia/etiologia , Humanos , Cirrose Hepática/sangue , Cirrose Hepática/complicações , Hormônio Luteinizante/sangue , Masculino , Prolactina/sangueRESUMO
The chain of events that results in increased production of nerve growth factor (NGF) following beta-adrenergic receptor (BAR) stimulation has been investigated in the C6-2B rat astrocytoma cell line. Exposure of these cells to the BAR agonist isoproterenol elicits the following cascade of events: (i) increase of cAMP content; (ii) increase of c-Fos mRNA content; (iii) accumulation of c-Fos protein immunoreactivity in the nucleus; (iv) increase of NGF mRNA content. The increase in c-Fos mRNA and its translation product are early events (15 and 40 min, respectively) and precede the accumulation of NGF mRNA, which peaks at 3 hr. The increase in the two mRNAs appears interrelated because cycloheximide inhibits the accumulation of c-Fos protein and NGF mRNA elicited by isoproterenol. Moreover, the accumulation of nuclear c-Fos protein and NGF mRNA induced by BAR stimulation is reduced by 2-aminopurine, an inhibitor of c-Fos mRNA induction. These data suggest that, in C6-2B astrocytoma cells, the nuclear accumulation of c-Fos protein is required for the induction of NGF mRNA expression by BAR stimulation.
Assuntos
Astrocitoma/fisiopatologia , Fatores de Crescimento Neural/biossíntese , Proteínas Proto-Oncogênicas/fisiologia , Receptores Adrenérgicos beta/fisiologia , 2-Aminopurina/farmacologia , Animais , Northern Blotting , AMP Cíclico/metabolismo , Cicloeximida/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Isoproterenol/farmacologia , Fatores de Crescimento Neural/genética , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas c-fos , RNA Mensageiro/genética , Ratos , Fatores de Tempo , Células Tumorais CultivadasRESUMO
C6-2B rat astrocytoma cells were used to test whether the increase of cellular nerve growth factor (NGF) content and secretion induced by isoproterenol treatment are associated with an increase in the content of mRNA that encodes NGF (NGF mRNA). Incubation of cells with isoproterenol (10 microM) for different time periods produced an increase of NGF mRNA content (3- to 5-fold over control) reaching maximum levels at 3 hr and lasting up to 24 hr. The isoproterenol effect on NGF mRNA was antagonized by the beta adrenergic receptor antagonist I-propranolol (10 microM) but not by phentolamine (10 microM), an alpha adrenergic receptor antagonist. When C6-2B astrocytoma cells were exposed for a short time to isoproterenol (10 microM; 10 or 20 min) followed by a washout period of 3 hr, the NGF mRNA content was increased by about 2-fold. The increase of NGF mRNA was obtained also with 10 microM prostaglandin E1 and this effect was potentiated by 100 microM of 3-isobutyl-1-methylxanthine. Inasmuch as both isoproterenol and prostaglandin E1 increase cyclic AMP content, one can surmise that cyclic AMP is involved in the stimulation of NGF mRNA accumulation. Whether cyclic AMP directly activates NGF gene transcription or activates an intermediate step, however, cannot be assessed by the present experiments.
Assuntos
Astrocitoma/metabolismo , Fatores de Crescimento Neural/genética , RNA Mensageiro/metabolismo , Receptores Adrenérgicos beta/metabolismo , Receptores de Prostaglandina/metabolismo , 1-Metil-3-Isobutilxantina/farmacologia , Alprostadil/farmacologia , Animais , Linhagem Celular , Isoproterenol/farmacologia , Masculino , Camundongos , Propranolol/farmacologia , Transcrição GênicaRESUMO
The pharmacokinetic pattern of erythromycin propionate-N-acetylcysteinate (EPAC) (erythromycin stinoprate I.N.N.), a new derivative, was studied on 12 healthy volunteers after single and multiple oral treatments. Microbiological and/or HPLC analytical methods were used to titer either erythromycin as base, propionate and total or N-acetylcysteine (NAC). In the acute experiment, a comparative evaluation was performed with erythromycin stearate (ES) and with N-acetylcysteine, according to a randomized-multi-crossover design. EPAC showed a better bioavailability than ES with longer-lasting serum levels of active antibiotic. NAC concentrations in the serum after EPAC were practically identical to those found after an oral administration of NAC alone. The multiple treatment study, performed in the same 12 volunteers with only EPAC, indicated that the pharmacokinetic pattern is somewhat different from that observed after a single dose, since higher concentrations were present at the steady state conditions.
Assuntos
Acetilcisteína/análogos & derivados , Acetilcisteína/farmacocinética , Eritromicina/análogos & derivados , Acetilcisteína/sangue , Adulto , Disponibilidade Biológica , Eritromicina/sangue , Eritromicina/farmacocinética , Feminino , Meia-Vida , Humanos , Masculino , Taxa de Depuração Metabólica , Pessoa de Meia-IdadeRESUMO
In C6-2B astrocytoma cells the Beta NGF content and secretion rate are increased by isoproterenol activation of beta-adrenergic receptors (Schwartz and Costa, 1977). Utilizing poly (A+) RNA hybridization analysis with a cRNA probe for mouse Beta NGF it was found that isoproterenol activation of C6-2B cells produces also a 4 fold increase of the content of messenger RNA encoding Beta NGF. This increase is specifically antagonized by 1-propanolol, but not by phentolamine. Furthermore, addition of dibutyryl-cAMP induces an increase of Beta NGF mRNA content similar to that obtained with isoproterenol. These results are consistent with the hypothesis that regulation of Beta NGF synthesis in neuroglial cells may be modulated by beta-adrenergic receptor activation.
Assuntos
Glioma/metabolismo , Fatores de Crescimento Neural/metabolismo , RNA Mensageiro/biossíntese , Receptores Adrenérgicos beta/fisiologia , Células Tumorais Cultivadas/metabolismo , Animais , Astrocitoma/metabolismo , Isoproterenol/farmacologia , RNA Mensageiro/isolamento & purificação , RatosRESUMO
The composition of the essential oil of Aframomum giganteum was investigated by GC-MS. Forty seven terpenes were identified, the oil contained a high percentage of linalool and linalyl acetate which are mainly responsible for the smell of the A. giganteum stems. Fatty acids, paraffins, n-octanol, n-nonanol and guaiacol were also identified.